Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease
To access this article, please choose from the options below
PII: S0954-6111(09)00097-3
doi:10.1016/j.rmed.2009.03.015
© 2009 Elsevier Ltd. All rights reserved.
